
He turned a fiddly, high-stakes moment in spine surgery into a business - and put a small Austin device company on shelves next to Medtronic.
AcuityMD is a Boston-based commercial intelligence platform built specifically for the medical device (MedTech) industry. It translates large volumes of healthcare claims and procedure data into intuitive workflows, AI-powered insights, and recommendations that help medical device sales and marketing teams find high-value physicians and care sites, size and segment markets, manage territories, and accelerate product adoption. Founded in 2019 by former MedTech and consulting operators, the company serves hundreds of device makers - including a majority of the largest MedTech firms - and raised an $80M Series C in 2026 at a near-$1B valuation.
David Carey is the Chief Executive Officer of Preceptis Medical, the Golden Valley, Minnesota company behind the Hummingbird Tympanostomy Tube System, an FDA-cleared device that lets clinicians place pediatric ear tubes in the office without general anesthesia. Appointed CEO in July 2025, Carey brings three decades of commercial leadership across the medical device industry, including senior roles at Pristine Surgical, Stryker, Medtronic, and Invuity, where he helped guide the company through an IPO before its acquisition by Stryker. At Preceptis, he is focused on scaling the Hummingbird device to more surgeons and families nationwide.